Liver News and Research

RSS

To be one in a million: ‘Who thinks it’s going to be you?’

Monica Melkonian wanted the Johnson & Johnson covid vaccine. It was only one shot and then she would be protected against the virus. So she was thrilled when the vaccination clinic at the Deschutes County Fair & Expo Center on April 7 had her first choice.

2 Mar 2022

Researchers reveal unique signature of genes expressed by hematopoietic stem cells

Hematopoietic stem cells (HSCs) have the capacity to both self-renew and differentiate into all mature blood cell types, making them promising treatments for a variety of diseases.

2 Mar 2022

New type of drug delivery vehicle mimics the properties of a red blood cell

From the liver to the kidneys to the lungs, the human body is equipped with many levels of filters, which protect the body from harmful outside materials. But this system also has its downsides. Critically important drugs such as chemotherapy or multiple sclerosis treatments are also foreign materials, so the body filters out a large portion of these drugs – up to 90%, in some cases.

2 Mar 2022

Drug misuse is not exclusive to the opioid epidemic, suggests study

Drug misuse is not exclusive to the opioid epidemic, according to a recent West Virginia University study. Every year, about 50,000 people in the United States are admitted to the emergency room due to misuse of a common over-the-counter pain medication – acetaminophen.

2 Mar 2022

Intestinal cells can change specializations during their lives, finds study

Intestinal cells can change specializations during their lives. The BMP signaling pathway – an important communication mechanism between cells – appears to be the driver of these changes.

1 Mar 2022

Scientists reveal molecular mechanisms behind bone loss caused by chronic liver injury

A research team led by Prof. Chen Di from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences along with other collaborators have revealed the molecular mechanisms behind bone loss caused by chronic liver injury.

1 Mar 2022

COVID-19 severity is correlated with body composition

In a recent study posted to the medRxiv* preprint server, researchers assessed the effect of changes in the abdominal well-being and physique on coronavirus disease 2019 (COVID-19) severity using magnetic resonance imaging (MRI).

28 Feb 2022

Microorganisms hindering cancer therapy have more influence than the beneficial ones, study says

Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

28 Feb 2022

Research shows intergenerational effects of preconception opioids in male offspring rats

New research from scientists at Cummings School of Veterinary Medicine at Tufts University suggests opioid use before pregnancy - even if not used during pregnancy itself - could result in a higher likelihood that a mother's male offspring will develop type 2 diabetes and metabolic syndrome, conditions that increase the risk of heart disease and stroke.

28 Feb 2022

Exercise may help reduce the risk of blood clots in patients with aggressive form of NAFLD

Exercise may help certain patients with nonalcoholic fatty liver disease (NAFLD) reduce their risk of developing blood clots, according to a new study by Penn State College of Medicine researchers.

28 Feb 2022

New signature initiative on increasing alcohol taxes could benefit people’s health, reduce mortality

Across the Region, alcohol consumption leads to almost one million deaths each year from a wide range of causes, including cardiovascular diseases, cancers and other noncommunicable diseases (NCDs), as well as infectious diseases and injuries.

28 Feb 2022

New trial aims to test a non-invasive treatment for early-stage liver cancer

Researchers are set to trial a non-invasive treatment for inoperable early-stage liver cancer, thanks to an injection of over $2 million in federal government funding.

25 Feb 2022

Research holds promise for improving asthma treatments for obese people

Over half of people with asthma are obese. These individuals do not respond well to standard therapies, but new research out of the Vermont Lung Center holds promise for improving asthma treatments for this population.

25 Feb 2022

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

Novocure announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption activates the immune system and triggers an anti-tumor cell response that may be effectively used together with existing immunotherapy approaches in the treatment of solid tumors, with limited systemic toxicity.

25 Feb 2022

Liver News and Research

To be one in a million: ‘Who thinks it’s going to be you?’

Researchers reveal unique signature of genes expressed by hematopoietic stem cells

New type of drug delivery vehicle mimics the properties of a red blood cell

Drug misuse is not exclusive to the opioid epidemic, suggests study

Intestinal cells can change specializations during their lives, finds study

Scientists reveal molecular mechanisms behind bone loss caused by chronic liver injury

COVID-19 severity is correlated with body composition

Microorganisms hindering cancer therapy have more influence than the beneficial ones, study says

Research shows intergenerational effects of preconception opioids in male offspring rats

Exercise may help reduce the risk of blood clots in patients with aggressive form of NAFLD

New signature initiative on increasing alcohol taxes could benefit people’s health, reduce mortality

New trial aims to test a non-invasive treatment for early-stage liver cancer

Research holds promise for improving asthma treatments for obese people

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

Study shows SARS-CoV-2 hijacks mitochondrial transcriptional machinery resulting in organ failure and death

Tiny lipid-based nanoparticles carry genetic instructions directly into the lungs

Study shows BCG vaccine provides no protection against SARS-CoV-2 in mice and hamsters

CD91 receptor promotes SARS-CoV-2 infection

Discovery could lead to new treatment approach for people with alcohol-associated liver disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News